Cargando…

γ-secretase inhibitor I inhibits neuroblastoma cells, with NOTCH and the proteasome among its targets

As high-risk neuroblastoma (NB) has a poor prognosis, new therapeutic modalities are needed. We therefore investigated the susceptibility of NB cells to γ-secretase inhibitor I (GSI-I). NOTCH signaling activity, the cellular effects of GSI-I and its mechanisms of cytotoxicity were evaluated in NB ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dorneburg, Carmen, Goß, Annika V., Fischer, Matthias, Roels, Frederik, Barth, Thomas F.E., Berthold, Frank, Kappler, Roland, Oswald, Franz, Siveke, Jens T., Molenaar, Jan J., Debatin, Klaus-Michael, Beltinger, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Priority Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325329/ https://www.ncbi.nlm.nih.gov/pubmed/27588497 http://dx.doi.org/10.18632/oncotarget.11715

Ejemplares similares

CHD5 inhibits metastasis of neuroblastoma
por: Laut, Astrid K., et al.
Publicado: (2021)

Proof-of-principle that a decoy virus protects oncolytic measles virus against neutralizing antibodies
por: Xu, Chun, et al.
Publicado: (2018)

The survivin-ran inhibitor LLP-3 decreases oxidative phosphorylation, glycolysis and growth of neuroblastoma cells
por: Galiger, Celimene, et al.
Publicado: (2023)

CD57(high) Neuroblastoma Cells Have Aggressive Attributes Ex Situ and an Undifferentiated Phenotype in Patients
por: Schlitter, Anne-Marie, et al.
Publicado: (2012)

Notch versus the proteasome: what is the target of γ-secretase inhibitor-I?
por: Clementz, Anthony G, et al.
Publicado: (2009)

MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in Neuroblastoma
por: Agarwal, Prasoon, et al.
Publicado: (2023)

The cytotoxicity of γ-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by γ-secretase inhibition
por: Han, Jianxun, et al.
Publicado: (2009)

PPP2CA Is a Novel Therapeutic Target in Neuroblastoma Cells That Can Be Activated by the SET Inhibitor OP449
por: Galiger, Celimene, et al.
Publicado: (2022)

Gamma secretase inhibitors of Notch signaling
por: Olsauskas-Kuprys, Roma, et al.
Publicado: (2013)

CFC1 is a cancer stemness-regulating factor in neuroblastoma
por: Chikaraishi, Koji, et al.
Publicado: (2017)

Monoubiquitination and endocytosis direct γ-secretase cleavage of activated Notch receptor
por: Gupta-Rossi, Neetu, et al.
Publicado: (2004)

Targeted parallel DNA sequencing detects circulating tumor‐associated variants of the mitochondrial and nuclear genomes in patients with neuroblastoma
por: Riehl, Lara, et al.
Publicado: (2022)

Comparison of SARS-CoV-2 RT-PCR on a high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the diagnostic of COVID-19 on various clinical samples
por: Opota, Onya, et al.
Publicado: (2020)

Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model
por: Hasan, Md. Nabiul, et al.
Publicado: (2014)

Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma
por: Bogen, Dominik, et al.
Publicado: (2015)

EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma
por: Hiddingh, Lotte, et al.
Publicado: (2013)

MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma
por: Fabian, Johannes, et al.
Publicado: (2016)

The mitochondrial genetic landscape in neuroblastoma from tumor initiation to relapse
por: Riehl, Lara M., et al.
Publicado: (2015)

Inhibition of Notch Signaling by a γ-Secretase Inhibitor Attenuates Hepatic Fibrosis in Rats
por: Chen, Yixiong, et al.
Publicado: (2012)

γ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer
por: Mizugaki, H, et al.
Publicado: (2012)

Long-term treatment with chloroquine increases lifespan in middle-aged male mice possibly via autophagy modulation, proteasome inhibition and glycogen metabolism
por: Doeppner, Thorsten R., et al.
Publicado: (2022)

Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastoma
por: Duffy, David J., et al.
Publicado: (2015)

Regulation of brown adipose tissue recruitment, metabolism and thermogenic function by peroxisome proliferator-activated receptor γ
por: Bolsoni-Lopes, Andressa, et al.
Publicado: (2015)

Sanpodo controls sensory organ precursor fate by directing Notch trafficking and binding γ-secretase
por: Upadhyay, Alok, et al.
Publicado: (2013)

Noncanonical SQSTM1/p62-Nrf2 pathway activation mediates proteasome inhibitor resistance in multiple myeloma cells via redox, metabolic and translational reprogramming
por: Riz, Irene, et al.
Publicado: (2016)

A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model
por: Aminzadeh-Gohari, Sepideh, et al.
Publicado: (2017)

FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors
por: O'Neil, Jennifer, et al.
Publicado: (2007)

Substrate docking to γ-secretase allows access of γ-secretase modulators to an allosteric site
por: Uemura, Kengo, et al.
Publicado: (2010)

c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expression
por: Cantrell, Michael A., et al.
Publicado: (2015)

Oxidative stress-induced MMP- and γ-secretase-dependent VE-cadherin processing is modulated by the proteasome and BMP9/10
por: Ivaldo, Caterina, et al.
Publicado: (2023)

Presenilin/γ-Secretase and Inflammation
por: Saura, Carlos A.
Publicado: (2010)

γ-Secretase in Alzheimer’s disease
por: Hur, Ji-Yeun
Publicado: (2022)

Inhibition of ADAM-17 more effectively down-regulates the Notch pathway than that of γ-secretase in renal carcinoma
por: Guo, Zhen, et al.
Publicado: (2013)

γ‐secretase inhibitor DAPT mitigates cisplatin‐induced acute kidney injury by suppressing Notch1 signaling
por: Soni, Hitesh, et al.
Publicado: (2018)

Inhibiting Notch Activity in Breast Cancer Stem Cells by Glucose Functionalized Nanoparticles Carrying γ-secretase Inhibitors
por: Mamaeva, Veronika, et al.
Publicado: (2016)

Notch signaling inactivation by small molecule γ-secretase inhibitors restores the multiciliated cell population in the airway epithelium
por: Vladar, Eszter K., et al.
Publicado: (2023)

FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma
por: Ackermann, Sandra, et al.
Publicado: (2014)

Gamma Secretase Inhibitors as Potential Therapeutic Targets for Notch Signaling in Uterine Leiomyosarcoma
por: Abedin, Yasmin, et al.
Publicado: (2022)

γ-Secretase modulators exhibit selectivity for modulation of APP cleavage but inverse γ-secretase modulators do not
por: Lessard, Christian B., et al.
Publicado: (2020)

γ‐Secretase modulators show selectivity for γ‐secretase–mediated amyloid precursor protein intramembrane processing
por: Weber, Tobias A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rpk54aud22fk7pguvn5fsqdunk